Perspective Therapeutics (CATX)

• Market cap: $535M
• 1 day: -6.37%
• 5 days: -0.42%
• 1 month: 87.25%
• 3 months: 127.05%
• 6 months: 23.36%
• Year to date: 68.46%
• 1 year: 51.13%
• 5 years: -73.45%
• 10 years: -31.88%
• Sector: Healthcare
• Industry: Medical Instruments & Supplies

About: Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

Employees: 140